Amgen Inc.
AMGN
$310.15
-$2.71-0.87%
Headlines
5/12/2024
-
Ticker Report
5/12/2024
-
Ticker Report
5/12/2024
-
Fool.com Headlines
5/11/2024
-
Ticker Report
5/11/2024
-
Ticker Report
5/10/2024
-
Ticker Report
5/10/2024
-
Insider Monkey
5/10/2024
-
Insider Monkey
5/10/2024
-
Orange County Register: Business
5/10/2024
-
The Mercury News: Health
5/10/2024
-
Orange County Register: Business
5/10/2024
-
Ticker Report
5/10/2024
-
Zacks Investment Research
5/10/2024
-
Bizjournals.com: Manufacturing
5/9/2024
-
Ticker Report
5/9/2024
-
Insider Monkey
5/9/2024
-
PR Newswire
5/9/2024
-
Ticker Report
5/9/2024
-
Stock Options Channel
5/9/2024
-
Ticker Report
5/9/2024
-
Seeking Alpha - Healthcare
5/9/2024
-
The Fly
5/9/2024
-
InvestorPlace
5/8/2024
-
Ticker Report
5/8/2024
-
Insider Monkey
Filings
Friday, May 3, 2024
Sunday, March 31, 2024
Beginning of August (est)
Price History
Corporate Info
805 447 1000
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Thousand Oaks, CA 91320-1799
Business Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and...
more